GE has already pulled in $100M from Olympics; Dental implant market predicted to grow 10% a year;

 @FierceMedDev: Another day, another Covidien 510(k) clearance, this time for a new bedside monitoring system. Report | Follow @FierceMedDev

 @MarkHFierce: Four years of working with FDA pays off. Proteus gained clearance for a new ingestible sensor. Release | Follow @MarkHFierce

 @DamianFierce: A new pig-flesh-based implant could make certain knee surgeries more successful. More | Follow @DamianFierce

> General Electric ($GE) says it sold about $100 million in medial devices, lights and other power supplies for the London Olympic Games, more than justifying its ongoing sponsorship. Story

> The North American dental implant market should grow at a robust 10% annual rate through 2016, according to a new report from Millennium Research Group. Release

> Patients with diabetes and morbid obesity have a higher risk of infection following hip and knee replacement, according to a new study published in the Journal of Bone and Joint Surgery. Story

> Bracco Diagnostics has secured FDA approval to expand its MultiHance agent for use in angiographic imaging. More

> Vermillion ($VRML) says it has generated positive results from a multi-center clinical study of its new ovarian cancer diagnostic involving 494 patients. Release

> Major state biotechnology lobbying groups in Illinois and Georgia are joining AdvaMed's state medical technology alliance, reflecting the increased interconnection between the biotech and medical device industries. Release

Biotech News

 @FierceBiotech: Models shed light on cocaine-curbing enzymes. More | Follow @FierceBiotech

 @JohnCFierce: Wall Street oddsmakers betting heavily against Lilly's solanezumab. News | Follow @JohnCFierce

 @RyanMFierce: Illumina is poised to grab more bioinformatics dollars with its cloud computing product, eventual app store. Release | Follow @RyanMFierce

> Shire's CEO, business model win accolades. Story

> Merck Serono launches first biotech spinout from Geneva wreckage. More

> Gilead preps late-stage sprint on blockbuster hep C studies. News

> FDA denies Otsuka and Lundbeck's antipsychotic drug. Article

Pharma News

 @FiercePharma: Endocyte poaches Novartis exec David Meek to be its chief commercial officer. Report | Follow @FiercePharma

> Shire CEO sees consumer-goods strategies in pharma's future. More

> Pay-for-delay deals could be upended by the Supreme Court. Article

CRO News

> Beta Pharma to manufacture Sunshine's targeted cancer drug. Story

> Quintiles inks deal to promote COPD drug in U.K. Article

> Analysts: CMO market will double by 2018. News

> 438 died in Indian clinical trials last year. Report

> Covance takes a $12.7M loss in Q2. News

Biotech IT News

> AZ's R&D information chief eyes improved trial success. Story

> Models shed light on cocaine-curbing enzymes. More

> Illumina seeks cut of bioinformatics biz with cloud system. Article

> AstraZeneca taps Amazon-like service for outsourcing research. News

> Complete Genomics, Ingenuity combine forces to understand genomes. Report

And Finally... Researchers and watchdogs are again urging the FDA to re-examine its policies on monitoring medical devices that transmit data wirelessly, warning that many techs are susceptible to tampering and data theft. News

Suggested Articles

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.

Illumina will drop $8 billion to reacquire its former spinout, which after nearly five years is nearing completion of its cancer-seeking blood test.

The CE Mark for the system’s fourth iteration follows a July 2019 approval from the FDA.